Skip to main content

Advertisement

SpringerLink
Log in

Nichtalkolische Fettlebererkrankungen

Neue und bewährte Therapieansätze bei NASH

Therapy of nonalcoholic steatohepatitis: the proven and the new

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Durch die weltweit zunehmende Prävalenz der Adipositas erkranken immer mehr Menschen an einer nichtalkoholischen Fettlebererkrankung (NAFLD). Bei ca. 30% entwickelt sich daraus eine nichtalkoholische Steatohepatitis (NASH). Wird diese nicht rechtzeitig erkannt und behandelt, drohen irreversible Schäden bis hin zu Karzinomen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Reccia I et al., Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism, 2017 Jul; 72: 94–108.

    Article  CAS  Google Scholar 

  2. Roeb E et al., S2k Guideline non-alcoholic fatty liver disease. Z Gastroenterol. 2015 Jul; 53 (7): 668–723.

    Article  CAS  Google Scholar 

  3. Caligiuri A et al., Molecular pathogenesis of NASH. Int J Mol Sci. 2016 Sep 20; 7 (9); 1–34.

    Google Scholar 

  4. Machado MV et al., Pathogenesis of non-alcoholic steatohepatitis. Gastroenterology. 2016 Jun; 150(8): 1769–77.

    Article  CAS  Google Scholar 

  5. Oh H et al., Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. Clin Mol Hepatol. 2016 Sep; 22(3): 327–335.

    Article  Google Scholar 

  6. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. EASL, EASD and EASO. J Hepatology 2016; 64: 1388 – 1402.

  7. Vilar-Gomez E et al., Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015; 149(2):367–78.

    Article  Google Scholar 

  8. Sanyal AJ et al., Pioglitazone, vitamin E, or placebo for non-alcoholic steatohepatitis. N Engl J Med. 2010; 362(18): 1675–85.

    Article  CAS  Google Scholar 

  9. Armstrong MJ et al., Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016; 387: 679–90.

    Article  CAS  Google Scholar 

  10. Neuschwander-Tetri BA et al., Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. NASH Clinical Research Network. Lancet. 2015; 385: 956–65.

    Article  CAS  Google Scholar 

  11. Ratziu V et al., GOLDEN-505 Investigator Study Group. Elafibranor, an agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology. 2016; 150(5):1147–1159.

    Article  CAS  Google Scholar 

  12. Friedman SL et al., A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Hepatology. 2017 Aug.

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin II, Thüringen-Kliniken „Georgius Agricola“ GmbH, Standort Saalfeld, Rainweg 68, D-07318, Saalfeld, Deutschland

    Peter C. Konturek (Chefarzt)

Authors
  1. Peter C. Konturek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter C. Konturek.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Konturek, P.C. Neue und bewährte Therapieansätze bei NASH. MMW - Fortschritte der Medizin 160, 50–54 (2018). https://doi.org/10.1007/s15006-018-0292-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-018-0292-8

Keywords

Search

Navigation